Skip to main content
. 2018 Jul 24;16(4):4353–4360. doi: 10.3892/ol.2018.9198

Figure 5.

Figure 5.

Line charts of serum cfDNA, CEA and CYFRA21-1 concentrations at serial time-points in patients with NSCLC. SD, stable disease; PR, partial response; PD, progressive disease; cfDNA, cell-free DNA; NSCLC, non-small cell lung cancer. Disease was detected by medical imaging.